• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Follow-up of patients with differentiated thyroid carcinoma. Experience at Institut Gustave-Roussy, Villejuif.

作者信息

Schlumberger M, Travagli J P, Fragu P, Gardet P, Lumbroso J, Parmentier C

机构信息

Institut Gustave-Roussy, Villejuif, France.

出版信息

Eur J Cancer Clin Oncol. 1988 Feb;24(2):345-50. doi: 10.1016/0277-5379(88)90278-7.

DOI:10.1016/0277-5379(88)90278-7
PMID:3356217
Abstract

The recent introduction of sTSH assays allows for a definite control of the inhibition of TSH secretion. Clinical examination and serum thyroid hormone measurements are necessary to obviate hyperthyroidism. Relapses may occur after decades of apparent complete remission. Follow-up should be pursued throughout the patient's lifetime. Two specific means allow the detection of relapses at a stage when X-rays are still normal: measurement of serum thyroglobulin and 131I total body scan. Their combined use is recommended.

摘要

相似文献

1
Follow-up of patients with differentiated thyroid carcinoma. Experience at Institut Gustave-Roussy, Villejuif.
Eur J Cancer Clin Oncol. 1988 Feb;24(2):345-50. doi: 10.1016/0277-5379(88)90278-7.
2
Is empiric 131I therapy justified for patients with positive thyroglobulin and negative 131I whole-body scanning results?对于甲状腺球蛋白阳性而131I全身扫描结果阴性的患者,经验性131I治疗是否合理?
J Nucl Med. 2005 Jul;46(7):1164-70.
3
Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients.七种血清甲状腺球蛋白检测方法在甲状腺乳头状癌和滤泡状癌患者随访中的比较
J Clin Endocrinol Metab. 2007 Jul;92(7):2487-95. doi: 10.1210/jc.2006-0723. Epub 2007 Apr 10.
4
Importance of postoperative stimulated thyroglobulin level at the time of 131I ablation therapy for differentiated thyroid cancer.分化型甲状腺癌131I消融治疗时术后刺激甲状腺球蛋白水平的重要性。
Asian Pac J Cancer Prev. 2014;15(6):2523-7. doi: 10.7314/apjcp.2014.15.6.2523.
5
Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma.甲状腺切除术后行¹³¹I残留甲状腺组织消融时的血清甲状腺球蛋白水平,有助于早期预测低危分化型甲状腺癌患者的临床复发情况。
J Clin Endocrinol Metab. 2005 Mar;90(3):1440-5. doi: 10.1210/jc.2004-1771. Epub 2004 Dec 21.
6
A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer.重组人促甲状腺素与甲状腺激素撤减用于检测甲状腺残留组织或癌症的比较。
J Clin Endocrinol Metab. 1999 Nov;84(11):3877-85. doi: 10.1210/jcem.84.11.6094.
7
The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the planning of therapy and follow-up of patients with differentiated thyroid carcinoma after surgery.锝-99m 甲氧基异丁基异腈闪烁扫描术在分化型甲状腺癌患者术后治疗规划及随访中的作用
Eur J Nucl Med. 2000 Apr;27(4):431-40. doi: 10.1007/s002590050527.
8
Radioiodine total body scan versus serum thyroglobulin levels in follow-up of patients with thyroid cancer.甲状腺癌患者随访中放射性碘全身扫描与血清甲状腺球蛋白水平的比较
Surgery. 1982 Jan;91(1):42-5.
9
The use of recombinant human TSH in the follow-up of differentiated thyroid cancer: experience from a large patient cohort in a single centre.重组人促甲状腺激素在分化型甲状腺癌随访中的应用:来自单中心大型患者队列的经验
Clin Endocrinol (Oxf). 2002 Feb;56(2):247-52. doi: 10.1046/j.0300-0664.2001.01425.x.
10
[Detection of recurrence in patients with differentiated epithelioma of the thyroid].[甲状腺分化型上皮瘤患者复发的检测]
Ann Med Interne (Paris). 1984;135(5):351-5.

引用本文的文献

1
Autosomal dominant polycystic kidney disease: a potential mistake in the interpretation of radioiodine whole-body scintigraphy.常染色体显性多囊肾病:放射性碘全身闪烁扫描解读中的一个潜在错误。
Radiol Case Rep. 2018 Mar 7;13(2):453-455. doi: 10.1016/j.radcr.2018.01.031. eCollection 2018 Apr.
2
False positive 131I total body scan due to bilateral polycystic renal disease.双侧多囊肾导致131I全身扫描出现假阳性
J Endocrinol Invest. 1997 Jun;20(6):342-4. doi: 10.1007/BF03350315.
3
Thyroid cancer: a review of treatment and follow-up.
甲状腺癌:治疗与随访综述
Ann Nucl Med. 1996 Feb;10(1):1-7. doi: 10.1007/BF03165047.
4
False positive 131I total body scan due to an ectasia of the common carotidis.由于颈总动脉扩张导致131I全身扫描出现假阳性。
J Endocrinol Invest. 1993 Mar;16(3):207-11. doi: 10.1007/BF03344949.
5
A new immunoradiometric assay (IRMA) system for thyroglobulin measurement in the follow-up of thyroid cancer patients.一种用于甲状腺癌患者随访中甲状腺球蛋白测量的新型免疫放射分析(IRMA)系统。
Eur J Nucl Med. 1991;18(3):153-7. doi: 10.1007/BF02262724.
6
The clinician and the thyroid.临床医生与甲状腺。
Eur J Nucl Med. 1991;18(9):761-78. doi: 10.1007/BF00956719.